Literature DB >> 16557760

Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model.

R A Finkelstein1, R C Hollingsworth.   

Abstract

The recently introduced choleragen-induced rat foot edema model has been employed as a bioassay for evaluating the immunogenicity of three purified preparations containing cholera exo-enterotoxin antigen, choleragen, choleragenoid, and Formalin-treated choleragen (formagen). The results indicated that choleragen evoked antitoxic immunity. Both the degree of resistance to challenge and the serum antibody levels of immunized animals were found to be related to the immunizing dose. Responses to the natural toxoid, choleragenoid, were erratic: some animals responded well and some failed to respond with either serum antibody or resistance to challenge. On the other hand, the artificially prepared toxoid, formagen, was found to be superior to the parent toxin in immunogenicity. Resistance to the choleragen-induced rat foot edema could be transferred passively by means of antibody-containing serum from previously immunized animals. Each of the antigens induced a state of hypersensitivity manifested by an immediate edematous response to challenge with either choleragen or choleragenoid. This condition, which was also passively transferable, suggests that untoward reactions should be anticipated in people receiving multiple doses of immunogens containing the cholera exo-enterotoxin antigen. Some of these observations were repeated, in a preliminary fashion, in an apparently equally suitable mouse foot edema model.

Entities:  

Year:  1970        PMID: 16557760      PMCID: PMC415926          DOI: 10.1128/iai.1.5.468-473.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

Review 1.  Cholera toxins.

Authors:  W Burrows
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

2.  Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs.

Authors:  R A Finkelstein; J J Jehl; A Goth
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

3.  Antitoxic immunity in experimental canine cholera.

Authors:  G T Curlin; A Subong; J P Craig; C C Carpenter
Journal:  Trans Assoc Am Physicians       Date:  1968

4.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

5.  Pathogenesis of experimental cholera. Effect of choleragen on vascular permeability.

Authors:  R A Finkelstein; S W Nye; P Atthasampunna; P Charunmethee
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

6.  Antitoxic immunity in experimental cholera: observations with purified antigens and the ligated ileal loop model.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

7.  In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.

Authors:  R A Finkelstein; J W Peterson
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

8.  Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.

Authors:  A S Benenson; W H Mosley; M Fahimuddin; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

9.  Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.

Authors:  A S Benenson; A Saad; W H Mosley; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  6 in total

1.  Systemic delayed-type hypersensitivity to cholera toxin and a detoxified derivative.

Authors:  R A Kay; A Ferguson
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

Review 2.  Vibrio cholerae enterotoxin and its mode of action.

Authors:  N F Pierce; W B Greenough; C C Carpenter
Journal:  Bacteriol Rev       Date:  1971-03

3.  Monospecific equine antiserum against cholera exo-enterotoxin.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

4.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

6.  Preparation of procoligenoids from Escherichia coli heat-labile enterotoxins.

Authors:  R A Finkelstein; C V Sciortino; L C Rieke; M F Burks; M Boesman-Finkelstein
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.